149 related articles for article (PubMed ID: 9384064)
1. HELIDAC therapy (bismuth subsalicylate/metronidazole/tetracycline hydrochloride).
Claussen DW
Gastroenterol Nurs; 1997; 20(5):188-9. PubMed ID: 9384064
[No Abstract] [Full Text] [Related]
2. Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
Patchin GM; Wieland KA; Carmichael JM
Am J Health Syst Pharm; 1996 Sep; 53(17):2081-2. PubMed ID: 8991624
[No Abstract] [Full Text] [Related]
3. Factors influencing the eradication of Helicobacter pylori with triple therapy.
Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
[TBL] [Abstract][Full Text] [Related]
4. Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Graham DY; Lew GM; Ramirez FC; Genta RM; Klein PD; Malaty HM
Aliment Pharmacol Ther; 1993 Feb; 7(1):111-3. PubMed ID: 8439632
[TBL] [Abstract][Full Text] [Related]
5. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
Graham DY; Hoffman J; el-Zimaity HM; Graham DP; Osato M
Aliment Pharmacol Ther; 1997 Oct; 11(5):935-8. PubMed ID: 9354203
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
[TBL] [Abstract][Full Text] [Related]
7. Eczema responsive to treatment for Helicobacter pylori.
Wilson WH
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):290. PubMed ID: 7552934
[No Abstract] [Full Text] [Related]
8. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
García Pérez A; Valverde de La Osa J; Giménez Samper M; Alonso García I
Sangre (Barc); 1999 Oct; 44(5):387-8. PubMed ID: 10618919
[No Abstract] [Full Text] [Related]
9. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
Peura DA; Graham DY
Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
[No Abstract] [Full Text] [Related]
10. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori.
Seifrit B
AORN J; 1997 Mar; 65(3):614-6, 619-20. PubMed ID: 9061156
[No Abstract] [Full Text] [Related]
12. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
[TBL] [Abstract][Full Text] [Related]
13. Short report: short-term triple therapy for H. pylori-associated duodenal ulcer disease.
Patchett S; Beattie S; Keane C; O'Morain C
Aliment Pharmacol Ther; 1992 Feb; 6(1):113-7. PubMed ID: 1543813
[TBL] [Abstract][Full Text] [Related]
14. Resolution of gastric outlet obstruction after eradication of Helicobacter pylori.
de Boer WA; Driessen WM
J Clin Gastroenterol; 1995 Dec; 21(4):329-30. PubMed ID: 8583113
[No Abstract] [Full Text] [Related]
15. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.
Lee M; Kemp JA; Canning A; Egan C; Tataronis G; Farraye FA
Arch Intern Med; 1999 Oct; 159(19):2312-6. PubMed ID: 10547171
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
Kadayifci A; Uygun A; Polat Z; Kantarcioğlu M; Kılcıler G; Başer O; Ozcan A; Emer O
Turk J Gastroenterol; 2012 Feb; 23(1):8-13. PubMed ID: 22505373
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
[TBL] [Abstract][Full Text] [Related]
18. Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
Tkach CL; Ariano RE
Ann Pharmacother; 1998 Mar; 32(3):387. PubMed ID: 9533072
[No Abstract] [Full Text] [Related]
19. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
Hosking SW; Ling TK; Chung SC; Yung MY; Cheng AF; Sung JJ; Li AK
Lancet; 1994 Feb; 343(8896):508-10. PubMed ID: 7906759
[TBL] [Abstract][Full Text] [Related]
20. Treating peptic ulcer: an ongoing challenge.
Cohen MH
J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
[No Abstract] [Full Text] [Related]
[Next] [New Search]
